Ozempic, Wegovy Risks Unveiled with Medical Research Mohit Sodhi
Krissy Vann | Host, All Things Fitness and Wellness
Are the medications we use for weight loss really as safe as they seem?
In the debut episode of the All Things Fitness and Wellness podcast's Exercise Snacks: Bite Size Science series, we dive into this critical question with Medical Researcher Mohit Sodhi, a rising star in healthcare featured in Forbes' Top 30 under 30. Sodhi recently grabbed the world's attention by uncovering the heightened risks associated with weight loss drugs like Ozempic and Wegovy. With an impressive portfolio boasting over 35 peer-reviewed publications, Sodhi takes us on a journey through the latest study findings, shedding light on the potential side effects of these widely-used medications.
The groundbreaking study Sodhi discusses focused on comparing the use of GLP-1 agonists for weight loss. The results, revealed in this episode, expose an increased risk of pancreatitis, gastroparesis, and bowel obstruction.
This revelation prompts us to consider the implications for individuals contemplating these drugs for weight loss. Despite their rarity, the risks must be weighed against the benefits, especially when considering how this risk-benefit calculation may differ for those seeking weight loss compared to those using these drugs for diabetes management. It is advisable for individuals initiating any medication to seek guidance from their healthcare provider.
Stay tuned for more eye-opening insights as Exercise Snacks: Bite Size Science drops new episodes every other Monday, providing a digestible dose of the latest science in the world of fitness and wellness.
Available on YouTube, Spotify, Apple Podcasts & more: Listen Here